About this trial

The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.

Eligibility criteria

Qualifiers

Patients with DM type 2 of more than 1-year duration

DM stage 3 or less

Patients ≥18 years of age

Refractory painful diabetic peripheral neuropathy of the lower extremities

Disqualifiers

Patients on anticoagulants

Patients with active infections

Patients with HbA1>10

Psychiatric disorders and cognitive dysfunctions

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

25 Participants
are grouped into 1 trial group

Locations

1
University of Chicago Medical Center60637, ChicagoIllinois, United States

Sponsors and collaborators

University of Chicago

Lead sponsor